莊士中國(00298.HK)完成出售番禺物業項目 已大幅加強集團財務狀況
格隆匯10月4日丨莊士中國(00298.HK)公吿,截至2021年9月30日止六個月,債券投資表現受到高收益債券市場欠佳及反覆波動的不利影響。期內,就債券投資而言,集團預計將錄得利息收入約4810萬港元、出售及贖回債券投資的已變現虧損約490萬港元,以及債券投資的未變現公平值虧損約2.56億港元。上述各項淨影響為虧損約2.13億港元。
集團已於2021年5月完成出售位於中國番禺的物業項目,代價約為人民幣15.7億元。該現金出售已大幅加強集團的財務狀況,並預期於截至2021年9月30日止六個月為集團產生龐大收益淨額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.